TR

Tyagaraja Ram Kumar

Active Director Designated Partner DIN 10294392
DIN 10294392 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Tyagaraja Ram Kumar

Data last updated:

Tyagaraja Ram Kumar is a Designated Partner at Dr Srm Biotech Pharma Llp (since 2023). The company operates in Paper.

DIN 10294392
Primary Designation Designated Partner
Industry Paper
First Appointment 25 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Aug 20232023Active

Board colleagues of Tyagaraja Ram Kumar

NameDINCompanyDesignation
Deepak Narayana Poojary10294393Dr Srm Biotech Pharma LlpDesignated Partner
Theeyara Babu Suji10294394Dr Srm Biotech Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dr Srm Biotech Pharma Llp
Premium access

Shareholding and investment profile for Tyagaraja Ram Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tyagaraja Ram Kumar

Tyagaraja Ram Kumar currently holds 1 directorship: Dr Srm Biotech Pharma Llp (Designated Partner, since 25 Aug 2023).

Tyagaraja Ram Kumar was first appointed on 25 Aug 2023 as Designated Partner at Dr Srm Biotech Pharma Llp.

The current boards of Tyagaraja Ram Kumar's companies include Deepak Narayana Poojary (Dr Srm Biotech Pharma Llp), Theeyara Babu Suji (Dr Srm Biotech Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available